The store will not work correctly when cookies are disabled.
N-benzyl-N-(2-((cyanomethyl)amino)-2-oxoethyl)-3-iodobenzamide
ID: ALA4874830
PubChem CID: 164627629
Max Phase: Preclinical
Molecular Formula: C18H16IN3O2
Molecular Weight: 433.25
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: N#CCNC(=O)CN(Cc1ccccc1)C(=O)c1cccc(I)c1
Standard InChI: InChI=1S/C18H16IN3O2/c19-16-8-4-7-15(11-16)18(24)22(13-17(23)21-10-9-20)12-14-5-2-1-3-6-14/h1-8,11H,10,12-13H2,(H,21,23)
Standard InChI Key: FYMOCLGENPGQER-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 25 0 0 0 0 0 0 0 0999 V2000
32.5624 -19.3938 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.5613 -20.2133 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.2693 -20.6223 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.9790 -20.2129 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.9761 -19.3902 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.2675 -18.9849 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.2691 -21.4395 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.9767 -21.8483 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.9765 -22.6655 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.6841 -23.0742 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.6845 -21.4398 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.3921 -21.8486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.3919 -22.6658 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
36.0999 -21.4402 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
36.8076 -21.8490 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.5154 -21.4405 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.2183 -21.0302 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.2713 -23.0748 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.5634 -22.6643 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.8561 -23.0720 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.8555 -23.8901 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.5681 -24.2987 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.2725 -23.8886 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.1487 -22.6629 0.0000 I 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
3 7 1 0
7 8 1 0
8 9 1 0
9 10 2 0
8 11 1 0
11 12 1 0
12 13 2 0
12 14 1 0
14 15 1 0
15 16 1 0
16 17 3 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
9 18 1 0
20 24 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 433.25 | Molecular Weight (Monoisotopic): 433.0287 | AlogP: 2.57 | #Rotatable Bonds: 6 |
Polar Surface Area: 73.20 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 11.53 | CX Basic pKa: ┄ | CX LogP: 2.36 | CX LogD: 2.36 |
Aromatic Rings: 2 | Heavy Atoms: 24 | QED Weighted: 0.56 | Np Likeness Score: -2.23 |
References
1. Alves L, Santos DA, Cendron R, Rocho FR, Matos TKB, Leitão A, Montanari CA.. (2021) Nitrile-based peptoids as cysteine protease inhibitors., 41 [PMID:33991733] [10.1016/j.bmc.2021.116211] |